<h3>Marking a significant milestone: on June 15th, 2023 the international patent application for ElderCraft&reg; has been published: &ldquo;ELDERBERRY EXTRACT FOR USE IN A METHOD OF PREVENTING OR TREATING SARS-CoV-2 INFECTION&rdquo;</h3>

<p>The laboratory headed by Prof. Schubert Institute of Virology, Friedrich-Alexander University Erlangen-N&uuml;rnberg studied the effect of <strong>ElderCraft&reg;</strong>, an extract made by IPRONA from Sambucus nigra, L. black elderberries (variety Haschberg) on the replication of SARS-CoV-2 coronavirus that causes COVID-19. The study revealed that <strong>ElderCraft&reg;</strong> inhibits at the replication of the virus in vitro.</p>

<p>Encouraged by these findings, IPRONA filed an international patent describing <strong>ElderCraft&reg;</strong> for use in the prevention and treatment of COVID-19.</p>

<p>Prof. Schubert points out that their recent research findings indicate the extract exhibits potent anti-SARS-CoV-2 activity. The remarkable efficacy of this extract is not confined to the Wuhan type of the virus; it extends equally to variants of concern Alpha, Beta, Gamma, Delta, and Omicron.</p>

<p><strong>ElderCraft&reg;</strong> is a branded, high-quality natural ingredient derived from the European Black Elderberry Extract, Sambucus nigra. This premium product is utilized worldwide as an ingredient in a variety of food supplements designed to boost immunity.</p>

<p>The extract is made by an entirely mechanical, solvent-free ultra-filtration process to enrich an active blend of polyphenols, anthocyanins, polysaccharides and berry micronutrients from &ldquo;Haschberg&rdquo; elderberries grown exclusively for Iprona in southeast Austria.&nbsp;</p>
